相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Alpha Interferon (IFN-α)-Induced MicroRNA-122 Negatively Affects the Anti-Hepatitis B Virus Efficiency of IFN-α
Junli Hao et al.
JOURNAL OF VIROLOGY (2013)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection
Verena Bihrer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Christian M. Lange et al.
JOURNAL OF HEPATOLOGY (2011)
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in Patients With Hepatocellular Carcinoma or Chronic Hepatitis
Jian Xu et al.
MOLECULAR CARCINOGENESIS (2011)
Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C
Kazutoyo Morita et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Characterization of extracellular circulating microRNA
Andrey Turchinovich et al.
NUCLEIC ACIDS RESEARCH (2011)
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Silvia Cermelli et al.
PLOS ONE (2011)
MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
Yi-Ping Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
Yi Zhang et al.
CLINICAL CHEMISTRY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
Associations Between Serum Lipids and Hepatitis C Antiviral Treatment Efficacy
Darmendra Ramcharran et al.
HEPATOLOGY (2010)
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
Rohit K. Jangra et al.
JOURNAL OF VIROLOGY (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
Magdalena Sarasin-Filipowicz et al.
NATURE MEDICINE (2009)
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of hepatitis C virus by microRNA-122
Catherine L. Jopling
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Pegylated Interferon-α-2a plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
Chen-Hua Liu et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment predictors of a sustained virologic response in hepatitis B and C
Annika Kau et al.
JOURNAL OF HEPATOLOGY (2008)
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Melissa Piper Hunter et al.
PLOS ONE (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interferon modulation of cellular microRNAs as an antiviral mechanism
Irene M. Pedersen et al.
NATURE (2007)
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection
G. W. McCaughan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
Ming-Lung Yu et al.
GUT (2007)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C
BL Bressler et al.
HEPATOLOGY (2003)
Identification of tissue-specific microRNAs from mouse
M Lagos-Quintana et al.
CURRENT BIOLOGY (2002)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
